ALPHA-ONOCERIN
![]() |
- $318 - $590
- Product name: ALPHA-ONOCERIN
- CAS: 511-01-3
- MF: C30H50O2
- MW: 442.72
- EINECS:208-118-6
- MDL Number:MFCD04972122
- Synonyms:(3beta,21alpha)-8,14-secogammacera-8(26),14(27)-diene-3,21-diol ;5β,5'β-Ethylenebis[(2S,8aα)-1,1,4aβ-trimethyl-6-methylenedecalin-2β-ol];8,14-Secogammacera-8(26),14(27)-diene-3β,21α-diol;alpha-Ocerol;alpha-Onocerol;ALPHA-ONOCERIN;Α-ONOCEROL;a-Onocerin
4 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- Arctom
- Crysdot
- Sigma-Aldrich
Package
- 5MG
- 10mg
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberSHG0005023
- Product descriptionALPHA-ONOCEROL 95.00%
- Packaging5MG
- Price$503.78
- Updated2021-12-16
- Buy
- ManufacturerArctom
- Product numberCFN98814
- Product descriptionalpha-Onocerol
- Packaging10mg
- Price$318
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD32001179
- Product descriptionα-Onocerin 95+%
- Packaging5mg
- Price$590
- Updated2021-12-16
- Buy
- ManufacturerSigma-Aldrich
- Product number05800590
- Product descriptionAlpha-onocerin primary reference standard
- Packaging10mg
- Price$491
- Updated2023-01-07
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
American Custom Chemicals Corporation | SHG0005023 | ALPHA-ONOCEROL 95.00% | 5MG | $503.78 | 2021-12-16 | Buy |
Arctom | CFN98814 | alpha-Onocerol | 10mg | $318 | 2021-12-16 | Buy |
Crysdot | CD32001179 | α-Onocerin 95+% | 5mg | $590 | 2021-12-16 | Buy |
Sigma-Aldrich | 05800590 | Alpha-onocerin primary reference standard | 10mg | $491 | 2023-01-07 | Buy |
Properties
Melting point :202-203 °C(Solv: chloroform (67-66-3); methanol (67-56-1))
Boiling point :524.3±50.0 °C(Predicted)
Density :1.01±0.1 g/cm3(Predicted)
pka :14.86±0.70(Predicted)
Boiling point :524.3±50.0 °C(Predicted)
Density :1.01±0.1 g/cm3(Predicted)
pka :14.86±0.70(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|